Management Team

Webcast

AxoGen Q1 2017 Earnings Call

Listen to the Webcast Replay
Kevin Leach

Kevin Leach

Mr. Leach brings 24 years of marketing and sales experience, having served in leadership positions of private and public companies addressing domestic and international markets in the medical device industry. Prior to joining AxoGen, Mr. Leach worked in a consulting capacity between September 2015 and March 2016 for start-up companies supporting strategic planning and due diligence activities for targeted acquisitions. He previously served as Vice President of Marketing for Stryker within their Orthopedic division, where he led the overall knee strategy from September 2013 through August 2015. From February 2013 to September 2013 he served as marketing consultant for SteadMed Medical, a medical device company focusing on acute and chronic wounds. From January 2008 to February 2013 he served in marketing roles with increasing responsibility and lastly Vice President, Marketing with ConvaTec, a medical products and technologies company with leading market positions in Wound Therapeutics, Ostomy Care, Continence and Infusion Devices. ConvaTec was acquired by Private Equity firms Nordic Capital and Avista Capital Partners in 2008. Prior to moving to the United States, Mr. Leach was a global marketing leader between October 2000 to January 2008 for ConvaTec, a Bristol-Myers Squibb company where he led the launch of new products globally. From February 1999 to October 2000 Mr. Leach served as Business Unit Manager at Zimmer UK, within a newly established division for the Orthopedic business unit focusing on market development and commercialization of an Injectable Hyaluronic Acid for the relief of joint pain. From January 1992 to February 1999 Mr. Leach held various sales and marketing roles within the UK division of ConvaTec. Mr. Leach received his Diploma in Podiatric Medicine from Queen Margaret University in Edinburgh.